These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immune-mediated skin disease in the dog and cat. Day MJ; Hanlon L; Powell LM J Comp Pathol; 1993 Nov; 109(4):395-407. PubMed ID: 8106669 [TBL] [Abstract][Full Text] [Related]
23. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant. Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441 [TBL] [Abstract][Full Text] [Related]
24. CCL3/MIP1α represents a biomarker but not a mandatory cytokine for disease development in experimental epidermolysis bullosa acquisita. Kasperkiewicz M; Kalies K; Pagel R; Bieber K; Zillikens D; Ludwig RJ J Dermatol Sci; 2017 Nov; 88(2):248-250. PubMed ID: 28711238 [No Abstract] [Full Text] [Related]
25. Epidermolysis bullosa acquisita with features of bullous lupus erythematosus. Prussick R; Gupta AK; Assaad DM; Hanna WM; Sauder DN Int J Dermatol; 1994 Mar; 33(3):192-5. PubMed ID: 8169020 [No Abstract] [Full Text] [Related]
26. Serum IgA autoantibodies in patients with epidermolysis bullosa acquisita: a high frequency of detection. Lee CW Dermatology; 2000; 200(1):83-4. PubMed ID: 10681627 [No Abstract] [Full Text] [Related]
27. Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita. Watanabe M; Natsuga K; Shinkuma S; Shimizu H J Dermatol; 2018 May; 45(5):515-521. PubMed ID: 29352483 [TBL] [Abstract][Full Text] [Related]
28. Epidermolysis Bullosa Acquisita Develops in Dominant Dystrophic Epidermolysis Bullosa. Hayashi R; Natsuga K; Watanabe M; Iwata H; Shinkuma S; Ito A; Masui Y; Ito M; Shimomura Y J Invest Dermatol; 2016 Jan; 136(1):320-3. PubMed ID: 26763454 [No Abstract] [Full Text] [Related]
29. Pathogenesis of epidermolysis bullosa acquisita. Ludwig RJ; Zillikens D Dermatol Clin; 2011 Jul; 29(3):493-501, xi. PubMed ID: 21605817 [TBL] [Abstract][Full Text] [Related]
30. Epidermolysis bullosa acquisita associated with epidermal-binding circulating antibodies. Wakelin SH; Bhogal B; Black MM; Allen J; Wojnarowska F; Hashimoto T; Farr PM; Swain AF Br J Dermatol; 1997 Apr; 136(4):604-9. PubMed ID: 9155969 [TBL] [Abstract][Full Text] [Related]
32. Detection of collagen VII autoantibodies to NC1 and NC2 domains of collagen VII by ELISA in suspected epidermolysis bullosa acquisita and bullous lupus erythematosus patients. Bain EE; Grover RK; Plunkett RW; Beutner EH J Dermatol Sci; 2012 Feb; 65(2):155-6. PubMed ID: 22225828 [No Abstract] [Full Text] [Related]
33. The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita. Marzano AV; Cozzani E; Biasin M; Russo I; Alaibac M Arch Dermatol Res; 2016 May; 308(4):273-6. PubMed ID: 26895535 [TBL] [Abstract][Full Text] [Related]
34. Inflammatory epidermolysis bullosa acquisita with coexistent IgA antibodies to plectin. Buijsrogge JJ; de Jong MC; Meijer HJ; Dijk F; Jonkman MF; Pas HH Clin Exp Dermatol; 2005 Sep; 30(5):531-4. PubMed ID: 16045687 [TBL] [Abstract][Full Text] [Related]